Mark Kelly

1.5k total citations · 1 hit paper
18 papers, 1.0k citations indexed

About

Mark Kelly is a scholar working on Epidemiology, Physiology and Molecular Biology. According to data from OpenAlex, Mark Kelly has authored 18 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 7 papers in Physiology and 5 papers in Molecular Biology. Recurrent topics in Mark Kelly's work include Adipose Tissue and Metabolism (7 papers), Adipokines, Inflammation, and Metabolic Diseases (6 papers) and Liver Disease Diagnosis and Treatment (4 papers). Mark Kelly is often cited by papers focused on Adipose Tissue and Metabolism (7 papers), Adipokines, Inflammation, and Metabolic Diseases (6 papers) and Liver Disease Diagnosis and Treatment (4 papers). Mark Kelly collaborates with scholars based in United States, Australia and Greece. Mark Kelly's co-authors include Timothy P. Fitzgibbons, Michael Czech, Matthias Nahrendorf, Jason D. Roh, Sean P. Arlauckas, Katherine A. Fitzgerald, Andrej Savol, Aaron D. Aguirre, Kevin R. King and Rainer H. Köhler and has published in prestigious journals such as Journal of Biological Chemistry, Nature Medicine and Nature Communications.

In The Last Decade

Mark Kelly

18 papers receiving 989 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

IRF3 and type I interferons fuel a fatal response to myocardial infarction

2017 412 citations Kevin R. King, Aaron D. Aguirre et al. Nature Medicine profile →

Peers

Countries citing papers authored by Mark Kelly

Since Specialization

Citations

This map shows the geographic impact of Mark Kelly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Kelly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Kelly more than expected).

Fields of papers citing papers by Mark Kelly

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Kelly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Kelly. The network helps show where Mark Kelly may publish in the future.

Co-authorship network of co-authors of Mark Kelly

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Kelly. A scholar is included among the top collaborators of Mark Kelly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Kelly. Mark Kelly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Lactate transporter MCT1 in hepatic stellate cells promotes fibrotic collagen expression in nonalcoholic steatohepatitis 2024 ·eLife ·(unknown), Batuhan Yenilmez, Mark Kelly, Dimas Echeverria, (unknown), Lawrence M. Lifshitz, (unknown), (unknown), (unknown), (unknown), Hui Wang, Nicholas McHugh, (unknown), Brett M. Morrison, Jeffery D. Rothstein, Anastasia Khvorova, Michael Czech	2
2	De novo lipogenesis fuels adipocyte autophagosome and lysosome membrane dynamics 2023 ·Nature Communications ·Leslie A. Rowland, Adı́lson Guilherme, Felipe Henriques, (unknown), (unknown), (unknown), Mark Kelly, (unknown), Gregory Hendricks, Meixia Pan, Xianlin Han, Olga Ilkayeva, Christopher B. Newgard, Michael Czech	28
3	Lactate transporter MCT1 in hepatic stellate cells promotes fibrotic collagen expression in nonalcoholic steatohepatitis 2023 ·eLife ·(unknown), Batuhan Yenilmez, Mark Kelly, Dimas Echeverria, (unknown), Lawrence M. Lifshitz, (unknown), (unknown), (unknown), (unknown), Hui Wang, Nicholas McHugh, (unknown), Brett M. Morrison, Jeffery D. Rothstein, Anastasia Khvorova, Michael Czech	9
4	Crosstalk between corepressor NRIP1 and cAMP signaling on adipocyte thermogenic programming 2023 ·Molecular Metabolism ·(unknown), Adı́lson Guilherme, Sarah M. Nicoloro, Mark Kelly, Lawrence M. Lifshitz, Hui Wang, (unknown), Leslie A. Rowland, (unknown), (unknown), Randall H. Friedline, Stacy A. Maitland, Min Chen, Lee S. Weinstein, Scot A. Wolfe, Jason K. Kim, Michael Czech	4
5	Acetyl-CoA carboxylase 1 is a suppressor of the adipocyte thermogenic program 2023 ·Cell Reports ·Adı́lson Guilherme, Leslie A. Rowland, (unknown), (unknown), (unknown), Alexander H. Bedard, Felipe Henriques, Mark Kelly, (unknown), David J. Pedersen, Olga Ilkayeva, Timothy R. Koves, (unknown), Meixia Pan, Xianlin Han, Jason K. Kim, Christopher B. Newgard, Deborah M. Muoio, Michael Czech	14
6	Paradoxical activation of transcription factor SREBP1c and de novo lipogenesis by hepatocyte-selective ATP-citrate lyase depletion in obese mice 2022 ·Journal of Biological Chemistry ·Batuhan Yenilmez, Mark Kelly, Guofang Zhang, (unknown), Olga Ilkayeva, (unknown), Leslie A. Rowland, (unknown), (unknown), (unknown), Lawrence M. Lifshitz, Meixia Pan, Xianlin Han, Jun Xie, Randall H. Friedline, Jason K. Kim, Guangping Gao, Mark A. Herman, Christopher B. Newgard, Michael Czech	19
7	An RNAi therapeutic targeting hepatic DGAT2 in a genetically obese mouse model of nonalcoholic steatohepatitis 2021 ·Molecular Therapy ·Batuhan Yenilmez, (unknown), Mark Kelly, Dimas Echeverria, (unknown), Lawrence M. Lifshitz, Julia F. Alterman, Matthew Hassler, (unknown), (unknown), Nicholas McHugh, (unknown), Jacquelyn Sousa, Meixia Pan, Xianlin Han, Michael A. Brehm, Anastasia Khvorova, Michael Czech	29
8	Control of Adipocyte Thermogenesis and Lipogenesis through β3-Adrenergic and Thyroid Hormone Signal Integration 2020 ·Cell Reports ·Adı́lson Guilherme, Batuhan Yenilmez, Alexander H. Bedard, Felipe Henriques, Dianxin Liu, Alexandra Lee, (unknown), Mark Kelly, Sarah M. Nicoloro, Min Chen, Lee S. Weinstein, Sheila Collins, Michael Czech	40
9	Single-Cell RNA Profiling Reveals Adipocyte to Macrophage Signaling Sufficient to Enhance Thermogenesis 2020 ·Cell Reports ·Felipe Henriques, Alexander H. Bedard, Adı́lson Guilherme, Mark Kelly, Jingyi Chi, Peng Zhang, Lawrence M. Lifshitz, Karl Bellvé, Leslie A. Rowland, Batuhan Yenilmez, (unknown), Yetao Wang, Jeremy Luban, Lee S. Weinstein, Jiandie D. Lin, Paul Cohen, Michael Czech	57
10	Neural JNK3 regulates blood flow recovery after hindlimb ischemia in mice via an Egr1/Creb1 axis 2019 ·Nature Communications ·Shashi Kant, Siobhan M. Craige, Kai Chen, (unknown), (unknown), Mark Kelly, (unknown), Khanh‐Van Tran, (unknown), Owen M. Peters, Marc Freeman, Roger J. Davis, John F. Keaney	26
11	Coronary disease is not associated with robust alterations in inflammatory gene expression in human epicardial fat 2019 ·JCI Insight ·Timothy P. Fitzgibbons, Nancy Lee, Khanh‐Van Tran, Sarah M. Nicoloro, Mark Kelly, Stanley Tam, Michael Czech	12
12	Neuronal modulation of brown adipose activity through perturbation of white adipocyte lipogenesis 2018 ·Molecular Metabolism ·Adı́lson Guilherme, David J. Pedersen, Felipe Henriques, Alexander H. Bedard, Elizabeth Henchey, Mark Kelly, Donald A. Morgan, Kamal Rahmouni, Michael Czech	29
13	CRISPR-delivery particles targeting nuclear receptor–interacting protein 1 (Nrip1) in adipose cells to enhance energy expenditure 2018 ·Journal of Biological Chemistry ·Yuefei Shen, Jessica Cohen, Sarah M. Nicoloro, Mark Kelly, Batuhan Yenilmez, Felipe Henriques, (unknown), Yvonne J. K. Edwards, Xiaodi Hu, Randall H. Friedline, Jason K. Kim, Michael Czech	47
14	IRF3 and type I interferons fuel a fatal response to myocardial infarction breakdown → 2017 ·Nature Medicine ·Kevin R. King, Aaron D. Aguirre, Yuxiang Ye, Yuan Sun, Jason D. Roh, Richard P Ng, Rainer H. Köhler, Sean P. Arlauckas, Yoshiko Iwamoto, Andrej Savol, Ruslan I. Sadreyev, Mark Kelly, Timothy P. Fitzgibbons, Katherine A. Fitzgerald, (unknown), Peter Libby, Matthias Nahrendorf, Ralph Weissleder	412
15	Map4k4 impairs energy metabolism in endothelial cells and promotes insulin resistance in obesity 2017 ·American Journal of Physiology-Endocrinology and Metabolism ·Rachel J. Roth Flach, Marina T. DiStefano, Laura V. Danai, Ozlem Senol-Cosar, Joseph C. Yawe, Mark Kelly, (unknown), Michael Czech	12
16	Protein Kinase Mitogen-activated Protein Kinase Kinase Kinase Kinase 4 (MAP4K4) Promotes Obesity-induced Hyperinsulinemia 2016 ·Journal of Biological Chemistry ·Rachel J. Roth Flach, Laura V. Danai, Marina T. DiStefano, Mark Kelly, (unknown), Agata Jurczyk, Rohit B. Sharma, Dae Young Jung, Jong Hun Kim, Jason K. Kim, Rita Bortell, Laura Alonso, Michael Czech	17
17	Development of an Ovine Model of Pediatric Complete Heart Block 2010 ·Journal of Surgical Research ·B. Sill, Nathalie Roy, Peter E. Hammer, John K. Triedman, Daniel C. Sigg, Mark Kelly, Arthur Nedder, Patricia Dunning, Douglas B. Cowan	6
18	Collagen‐platelet rich plasma hydrogel enhances primary repair of the porcine anterior cruciate ligament 2006 ·Journal of Orthopaedic Research® ·Martha M. Murray, Kurt P. Spindler, Eduardo Abreu, John A. Muller, Arthur Nedder, Mark Kelly, John Frino, David Zurakowski, (unknown), Brian D. Snyder, Susan A. Connolly	244

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact